Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 6,092 | 7,492 | 7,845 | 8,412 | 9,132 |
| Operating Income | -6,092 | -7,492 | -7,845 | -8,412 | -9,132 |
| Other Income | -51 | 40 | 131 | 16 | 227 |
| Pre-tax Income | -6,143 | -7,452 | -7,714 | -8,396 | -8,905 |
| Net Income Continuous | -6,143 | -7,452 | -7,714 | -8,396 | -8,905 |
| Net Income | $-6,143 | $-7,452 | $-7,714 | $-8,396 | $-8,905 |
| EPS Basic Total Ops | -44.06 | -53.99 | -55.79 | -59.39 | -68.39 |
| EPS Basic Continuous Ops | -44.09 | -53.40 | -55.35 | -60.24 | -68.57 |
| EPS Diluted Total Ops | -44.06 | -53.99 | -55.79 | -59.39 | -68.39 |
| EPS Diluted Continuous Ops | -44.09 | -53.40 | -55.35 | -60.24 | -68.57 |
| EBITDA(a) | $-6,052 | $-7,476 | $-7,845 | $-8,297 | $-9,100 |